Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration

Enrico Borrelli; Giulia Coco; Marco Pellegrini; Marco Mura; Nicolò Ciarmatori; Vincenzo Scorcia; Adriano Carnevali; Andrea Lucisano; Massimiliano Borselli; Costanza Rossi; Michele Reibaldi; Federico Ricardi; Aldo Vagge; Massimo Nicolò; Paolo Forte; Antonio Cartabellotta; Murat Hasanreisoğlu; Cem Kesim; Sibel Demirel; Özge Yanık; Federico Bernabei; Pierre-Raphaël Rothschild; Sarah Farrant; Giuseppe Giannaccare

doi:10.1007/s40123-024-01030-w

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Photobiomodulation (PBM) has become a promising approach for slowing the progression of early and intermediate dry age-related macular degeneration (dAMD) to advanced AMD. This technique uses light to penetrate tissues and activate molecules that influence biochemical reactions and cellular metabolism. This preliminary analysis is aimed at assessing the safety, tolerability, and short-term effectiveness of the EYE-LIGHT

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Borrelli et al. (2024) studied this question.

synapsesocial.com/papers/68e58930b6db643587525412 https://doi.org/10.1007/s40123-024-01030-w

View Full Paper

Ask AI

Bookmark

Share

Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration

Ask about this paper

Abstract

Discussion

Cite This Study

Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading